MoniDose featured in Life Science Sweden — Aurevia case study on regulatory confidence
On 25 March 2026, Aurevia published a case study on the Life Science Sweden portal describing how MoniDose built its regulatory confidence using the Lean Entries tool. In the piece, MoniDose CEO Alaa Salonen describes how Entries helped the team capture critical regulatory design inputs early and convince investors of the clarity of their compliance strategy.
On 25 March 2026, Aurevia published a case study on the Life Science Sweden portal highlighting a key turning point in MoniDose's regulatory journey. The piece focuses on how an early-stage medical device startup can build a strong regulatory foundation without facing costly redesigns later.
Key messages
According to the article, MoniDose's biggest challenge as a startup was regulatory uncertainty. Missed early-stage design inputs tied to standards and regulations could have caused significant costs further along the product development path.
Aurevia's Lean Entries tool changed the picture by:
✔ Ensuring all critical regulatory design inputs were captured early ✔ Raising the team's confidence in their compliance strategy ✔ Helping convince investors they had regulatory clarity and a focused regulatory strategy
What MoniDose says
> "Entries was game-changing… it gave us clarity, confidence, and a foundation we couldn't replace with any other tool — or even with AI." > > — Alaa Salonen, CEO and Founder of MoniDose
Why this matters
Beyond building a strong regulatory foundation, MoniDose has shown the kind of determined momentum seen in successful healthtech startups. Their intelligent medication dispensing solution is gaining recognition in Finland and abroad, supported by a clear market need and a scalable product vision. The team has also attracted notable early-stage investors, further strengthening confidence in the company's efficient path toward market entry.
About Aurevia
The Life Science Sweden piece highlights the support Aurevia provides to early-stage medical device companies — helping them build structure, clarity, and regulatory confidence. Aurevia is an Uppsala-based consultancy whose services include quality and regulatory affairs support led by its QARA team.
Contact: Anna-Karin Alm, Head of QARA, anna-karin.alm@aurevia.com
Originally published on Life Science Sweden on 25 March 2026 as sponsored content from Aurevia.